Biotricity Inc. (BTCY) stock
BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.05+0.00 (+8.70%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Biotricity cash
Cash and short-term investments held at the end of each period.
Biotricity's cash was $466.50K at Jun 30, 2026. For fiscal 2026 it was $149.79K, down 59.0% from the year before. The highest annual figure on record is $12.07M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $149.79K | -59.0% |
| FY2025 | Mar 31, 2025 | $365.15K | -53.5% |
| FY2024 | Mar 31, 2024 | $786.06K | +37.8% |
| FY2023 | Mar 31, 2023 | $570.46K | -95.3% |
| FY2022 | Mar 31, 2022 | $12.07M | +448.1% |
| FY2021 | Mar 31, 2021 | $2.20M | +131.8% |
| FY2020 | Mar 31, 2020 | $949.85K | +1392.4% |
| FY2019 | Mar 31, 2019 | $63.65K | -92.5% |
| FY2018 | Mar 31, 2018 | $843.64K | – |
| FY2014 | Aug 31, 2014 | $0 | – |
| FY2013 | Aug 31, 2013 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $466.50K | +19.2% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $149.79K | -59.0% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $256.36K | -49.7% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $308.46K | +78.0% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $391.29K | +288.5% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $365.15K | -53.5% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $509.60K | +498.9% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $173.27K | -85.6% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $100.73K | +95.8% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $786.06K | +37.8% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $85.09K | -81.1% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $1.20M | -52.0% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $51.43K | -99.6% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $570.46K | -96.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $451.42K | -96.1% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $2.50M | +1139.1% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $12.07M | +448.1% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $16.79M | +405.1% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $11.69M | +2387.3% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $201.59K | +210.7% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $2.20M | +131.8% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $3.32M | -23.6% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $470.17K | +1000.3% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $64.88K | +35.9% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $949.85K | +1392.4% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $4.35M | +16815.7% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $42.73K | -48.7% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $47.75K | -94.3% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $63.65K | -97.4% |
| Q1 FY2019CQ2 2018 | Dec 31, 2018 | $25.74K | -95.8% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $83.25K | -93.0% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $843.64K | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $2.48M | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $607.15K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $1.19M | – |
| Q4 FY2014CQ3 2014 | Aug 31, 2014 | $0 | – |
| Q3 FY2014CQ2 2014 | May 31, 2014 | $0 | – |
| Q4 FY2013CQ3 2013 | Aug 31, 2013 | $0 | – |
See a number that looks wrong?